NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 144 filers reported holding NOVAVAX INC in Q3 2014. The put-call ratio across all filers is 5.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $23,000 | +4.5% | 17,381 | -0.2% | 0.00% | 0.0% |
| Q1 2017 | $22,000 | -57.7% | 17,416 | -57.5% | 0.00% | 0.0% |
| Q4 2016 | $52,000 | -78.2% | 40,944 | -64.4% | 0.00% | -83.3% |
| Q3 2016 | $239,000 | -3.2% | 115,000 | +228.7% | 0.01% | -25.0% |
| Q3 2015 | $247,000 | -8.2% | 34,988 | +44.8% | 0.01% | 0.0% |
| Q2 2015 | $269,000 | -87.3% | 24,158 | -90.6% | 0.01% | -88.2% |
| Q1 2015 | $2,122,000 | +53.1% | 256,588 | -14.5% | 0.07% | +28.3% |
| Q2 2014 | $1,386,000 | +919.1% | 300,000 | +902.0% | 0.05% | +783.3% |
| Q1 2014 | $136,000 | -1.4% | 29,939 | +11.2% | 0.01% | -14.3% |
| Q4 2013 | $138,000 | – | 26,930 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |